ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences

Rhea-AI Summary

ImageneBio (Nasdaq: IMA) announced management will participate in fourth-quarter 2025 investor conferences with live webcasts and archived recordings available on the company investor relations site.

Scheduled appearances: Stifel Healthcare Conference fireside chat on Thursday, November 13, 2025 at 9:20 AM ET in New York, and Piper Sandler 37th Annual Healthcare Conference fireside chat on Thursday, December 4, 2025 at 10:00 AM ET in New York.

SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA, “Imagene,” “Company”), a clinical-stage biotechnology company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases, including IMG-007, an anti-OX40 monoclonal antibody with multiple differentiating features, today announced management participation in fourth quarter investor conferences.

2025 Stifel Healthcare Conference
Fireside Chat: Thursday, November 13, 9:20am EST
New York, NY

Piper Sander 37^th Annual Healthcare Conference
Fireside Chat: Thursday, December 4, 10:00am EST
New York, NY

To access the live webcasts or subsequent archived recordings of the presentation and fireside chat, please visit the ImageneBio IR Site.

About ImageneBio, Inc.
ImageneBio is a clinical-stage biotechnology company dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases with differentiated clinical profiles. The company’s lead asset, IMG-007, is a receptor targeting, nondepleting anti-OX40 monoclonal antibody with multiple differentiating features. Imagene has completed Phase 1b/2a clinical trials of IMG-007 in both atopic dermatitis and alopecia areata and is currently conducting a Phase 2b clinical trial of IMG-007 in patients with moderate-to-severe atopic dermatitis. For more information, please visit www.imagenebio.com.

Investor and Media Contact:
ir@imagenebio.com

FAQ

When will ImageneBio (IMA) present at the Stifel Healthcare Conference in 2025?

ImageneBio management will present on Thursday, November 13, 2025 at 9:20 AM ET.

What time is ImageneBio's (IMA) Piper Sandler conference fireside chat in December 2025?

The Piper Sandler fireside chat is scheduled for Thursday, December 4, 2025 at 10:00 AM ET.

How can investors watch ImageneBio (IMA) conference presentations live?

Investors can access live webcasts via the ImageneBio investor relations site.

Will archived recordings of ImageneBio (IMA) presentations be available after the events?

Yes, archived recordings will be available on the ImageneBio investor relations site after the live webcasts.

What topics is ImageneBio (IMA) expected to cover at the Q4 2025 investor conferences?

Management will discuss company developments and clinical programs such as IMG-007 (anti-OX40).

Where are the Stifel and Piper Sandler conferences taking place for ImageneBio (IMA) in Q4 2025?

Both the Stifel Healthcare Conference and Piper Sandler 37th Annual Healthcare Conference are in New York, NY.